We are live on ! Find out more
HIM

Hillhouse Investment Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 7.29%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
-7.29%
3 Year Est. Return
+122.05%
5 Year Est. Return
+101.44%
10 Year Est. Return
AUM
$5.89B
AUM Growth
-$162M
Cap. Flow
-$377M
Cap. Flow %
-6.4%
Top 10 Hldgs %
82.52%
Holding
50
New
2
Increased
8
Reduced
7
Closed
5

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$288M
2
BKNG icon
Booking.com
BKNG
+$201M
3
BABA icon
Alibaba
BABA
+$102M
4
SOHU
Sohu.com
SOHU
+$89.9M
5
BITA
Bitauto Holdings Limited
BITA
+$50.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 49.71%
2 Healthcare 12.65%
3 Consumer Staples 10.95%
4 Communication Services 8.17%
5 Financials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOK
26
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$19.7M 0.34%
469,000
+276,787
+144% +$10.7M
BRK.A icon
27
Berkshire Hathaway Class A
BRK.A
$1.12T
$19M 0.32%
64
SCHW
28
Charles Schwab
SCHW
$187B
$17.5M 0.3%
339,782
CHTR icon
29
Charter Communications
CHTR
$18.2B
$16.7M 0.28%
49,603
LN
30
DELISTED
LINE Corporation
LN
$13.8M 0.23%
336,800
AMZN icon
31
Amazon
AMZN
$2.96T
$13.5M 0.23%
231,240
VRSN icon
32
VeriSign
VRSN
$26.6B
$13.4M 0.23%
117,264
MCO icon
33
Moody's
MCO
$82.7B
$13.3M 0.23%
89,949
TIG
34
DELISTED
TiGenix American Depositary Shares
TIG
$11.1M 0.19%
483,870
SPGI icon
35
S&P Global
SPGI
$120B
$9.86M 0.17%
58,187
CCJ icon
36
Cameco
CCJ
$42.4B
$9.47M 0.16%
1,025,700
GTHX
37
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$8.93M 0.15%
450,000
SFUN
38
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$8.37M 0.14%
30,000
CLSD
39
DELISTED
Clearside Biomedical
CLSD
$6.61M 0.11%
62,947
+2,947
+5% +$316K
IDXX icon
40
Idexx Laboratories
IDXX
$46.2B
$6.53M 0.11%
41,725
KA
41
DELISTED
Kineta, Inc. Common Stock
KA
$5.05M 0.09%
6,185
NBRV
42
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.8M 0.08%
3,209
TSRO
43
DELISTED
TESARO, Inc.
TSRO
$3.07M 0.05%
37,100
BKNG icon
44
Booking.com
BKNG
$161B
$2.38M 0.04%
34,175
-2,774,375
-99% -$201M
SNDX icon
45
Syndax Pharmaceuticals
SNDX
$1.82B
$1.79M 0.03%
203,915
-27,118
-12% -$268K
MYND
46
Mynd.ai
MYND
$19.3M
-43,000
Closed -$12.3M
SOHU
47
Sohu.com
SOHU
$357M
-1,650,727
Closed -$89.9M
ITCI
48
DELISTED
Intra-Cellular Therapies Inc.
ITCI
-1,000,000
Closed -$15.8M
JNCE
49
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
-130,000
Closed -$2.02M
BITA
50
DELISTED
Bitauto Holdings Limited
BITA
-1,124,017
Closed -$50.2M

Similar funds

Hillhouse Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Hillhouse Investment Management held 50 positions worth $5.89B, down 2.7% from $6.05B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Hillhouse Investment Management withdrew a net $377M in Q4 2017, closing 5 positions and reducing 7 holdings. Its most notable exit was Sohu.com, an estimated $89.9M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, down from 55% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Hillhouse Investment Management opened a new position in Hello Group worth $53.2M.

  • Hillhouse Investment Management's largest Q4 2017 buy was Hello Group: 2,173,457 shares worth $53.2M.
  • Hillhouse Investment Management added most to TAL Education Group in Q4 2017, an estimated $157M increase.
  • Hillhouse Investment Management's biggest Q4 2017 reduction was JD.com, cutting an estimated $288M.
  • Hillhouse Investment Management fully exited Sohu.com in Q4 2017, selling an estimated $89.9M.
  • Hillhouse Investment Management's ten largest holdings make up 83% of its $5.89B portfolio in Q4 2017.
  • Hillhouse Investment Management opened 2 new positions and closed 5 in Q4 2017.
  • Hillhouse Investment Management's portfolio value fell 2.7% quarter-over-quarter to $5.89B.

Based on Hillhouse Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.